Cumberland Pharmaceuticals (CPIX) Retained Earnings (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Retained Earnings across 17 years of filings, most recently posting -$30.1 million for Q1 2026.

• Retained Earnings for Q1 2026 came in at -$30.1 million, down 32.51% year-over-year; the trailing twelve-month figure through Mar 2026 was -$30.1 million (down 32.51% YoY), and the FY2025 annual result was -$26.8 million, down 11.83% from the prior year.
• Retained Earnings came in at -$30.1 million for Q1 2026 at Cumberland Pharmaceuticals, down from -$26.8 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$7.0 million in Q1 2022 to a low of -$30.1 million in Q1 2026.
• The 5-year median for Retained Earnings is -$19.4 million (2024), against an average of -$17.6 million.
• Across the five-year window, Retained Earnings sank 1036.38% in 2022 and dropped 11.83% in 2025, its largest moves.
• Cumberland Pharmaceuticals' Retained Earnings stood at -$11.2 million in 2022, then tumbled by 56.02% to -$17.5 million in 2023, then tumbled by 37.05% to -$24.0 million in 2024, then fell by 11.83% to -$26.8 million in 2025, then slipped by 12.27% to -$30.1 million in 2026.
• The last three Retained Earnings figures came in at -$30.1 million (Q1 2026), -$26.8 million (Q4 2025), and -$25.4 million (Q3 2025), per Business Quant data.